A CASE OF EXTRANODAL NK/T-CELL LYMPHOMA PRESENTING WITH EOSINOPHILIA
Abstract
Background. Eosinophilia can occur in extranodal NK/T-cell lymphoma. Chronic hypereosinophilia from any cause is associated with endomyocardial fibrosis.
Methods and material. This report includes on a patient with hypereosinophilia, which was diagnosed and investigated nine months before the diagnosis of extranodal NK/T-cell lymphoma (nasal type) of the larynx was confirmed by biopsy. He died with signs of heart failure 11 months after the first symptoms developed. Post mortem investigation revealed endomyocardial fibrosis as a result of chronic hypereosinophilia.
Conclusions. To our knowledge eosinophilia has not previously been reported in extranodal NK/T-cell lymphoma (nasal type). Therefore, this is considered to be a rare feature of the presented case. Investigation of the heart for potential silent complications of prolonged and severe eosinophilia has to be considered at an early stage
Downloads
References
Lee PY, Freeman NJ, Khorsand J et al. Angiocentric T-cell lymphoma presenting as lethal midline granuloma. International J Dermatol 1997; 36: 419–27.
Thorp MA, Langman G, Sellars SL. Angiocentric T-cell lymphoma: an extensive lesion involving the posterior tongue, hypopharynx and supraglotis. J Laryngol Otol 1999; 113: 263–5.
Aviles A, Diaz NR, Neri N et al. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haem 2000; 22: 215–20.
Isoda K, Mizutani H, Nishiguci T et al. EB virus – related angiocentric T-cell lymphoma. Int J Derma 1998; 37: 37–51.
Wenig BM. Atlas of head and neck pathology. Philadelphia: Saunders 1993: 72–4.
Murata K, Yamada Y, Kamihira S et al. Frequency of eosinophilia in adult T-cell leukemia/lymphoma. Cancer 1992; 69: 966–71.
Monsuez JJ, Kerviler E, Barboteu M et al. Non-Hodgkin’s lymphoma related eosinophilic endomyocardial disease. Euro Heart J 1994; 15: 1423–7.
Dargent JL, Jacobovitz D, Pradier O et al. A case of pleomorphic T-cell lymphoma with high content of reactive histiocytes presented with hypereosinophilia. Path Res Pract 1995; 191: 463–8.
Zenone T, Feldman P, Malcus C et al. Indolent course of a patient with hypereosinophilic syndrome associated with clonal T-cell proliferation. Am J Med 1999; 107: 509–11.
Beutler E, Lichtman MA, Coller BS et al. Williams Haematology. Sixth edition. New York: The Mcgraw-Hill Companies, 2001: 844–50.
Mosqueda-Taylor A, Meneses-Garcia A, Zarate-Osorno A et al. Angiocentric lymphomas of the palate: clinico-pathological consideration in 12 cases. J Oral Pathol Med 1997; 26: 93–7.
Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592–600.
Bain BJ. Eosinophilia – Idiopathic or not? N Engl J Med 1999; 341: 1141–3.
Schleimer RP, Bocher BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994; 94: 1202–13.
Greer JP, York JC, Cousar JB et al. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J Clin Oncol 1984; 2: 788–98.
Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NU/T-cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, Vardiman JW eds. Geneva: World Health Organisation, 2001.
Bain BJ. Hypereosinophilia. Curr Opin Hematology 2000; 7: 21–5.
Davidson SP, Haberman TM, Strickler JG, DeRemee RA, Earle JD, McDonald TJ. Nasal and nasopharyngeal angiocentric T-cell lymphomas. Laryngoscope 1996; 106: 139–43.
O’Leary G, Kennedy SM. Association of Epstein-Barr virus with sinonasal angiocentric T cell lymphoma. J Clin Pathol 1995; 48: 946–9.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.